Archives of Pediatric Infectious Diseases

Published by: Kowsar

Diagnosis and Management of Recurrent Respiratory Tract Infections in Children: A Practical Guide

Urs Beat Schaad 1 , * , Susanna Esposito 2 and Cem Hasan Razi 3
Authors Information
1 Division of Pediatric Infectious Diseases, University Children’s Hospital, Basel, Switzerland
2 Department of Pathophysiology and Transplantation, Major Policlinics Hospital, Pediatric Highly Intensive Care Unit, IRCCS Ca’ Granda Fundation, University of Milan, Milan, Italy
3 Department of Pediatric Allergy, Acibadem Private Hospital, Ankara, Turkey
Article information
  • Archives of Pediatric Infectious Diseases: January 01, 2016, 4 (1); e31039
  • Published Online: December 27, 2015
  • Article Type: Review Article
  • Received: June 25, 2015
  • Revised: September 7, 2015
  • Accepted: October 18, 2015
  • DOI: 10.5812/pedinfect.31039

To Cite: Schaad U B, Esposito S, Razi C H. Diagnosis and Management of Recurrent Respiratory Tract Infections in Children: A Practical Guide, Arch Pediatr Infect Dis. 2016 ; 4(1):e31039. doi: 10.5812/pedinfect.31039.

Copyright © 2015, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Conclusions
  • 1. Ferkol T, Schraufnagel D. The global burden of respiratory disease. Ann Am Thorac Soc. 2014; 11(3): 404-6[DOI][PubMed]
  • 2. Bellanti JA. Recurrent respiratory tract infections in paediatric patients. Drugs. 1997; 54 Suppl 1: 1-4[PubMed]
  • 3. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008; 86(5): 408-16[PubMed]
  • 4. Wardlaw T, Salama P, Johansson EW, Mason E. Pneumonia: the leading killer of children. Lancet. 2006; 368(9541): 1048-50[DOI][PubMed]
  • 5. Wald ER, Guerra N, Byers C. Upper respiratory tract infections in young children: duration of and frequency of complications. Pediatrics. 1991; 87(2): 129-33[PubMed]
  • 6. Mistry RD, Fischer JB, Prasad PA, Coffin SE, Alpern ER. Severe complications in influenza-like illnesses. Pediatrics. 2014; 134(3)-90[DOI][PubMed]
  • 7. Szabo SM, Gooch KL, Korol EE, Bradt P, Mitchell I, Vo P, et al. A population-based study of childhood respiratory morbidity after severe lower respiratory tract infections in early childhood. J Pediatr. 2014; 165(1): 123-128 e3[DOI][PubMed]
  • 8. Neuman MI, Hall M, Gay JC, Blaschke AJ, Williams DJ, Parikh K, et al. Readmissions among children previously hospitalized with pneumonia. Pediatrics. 2014; 134(1): 100-9[DOI][PubMed]
  • 9. Eggenberger K. Respiratory tract infections most frequently seen in pediatric outpatient care. Ars Medici. 1993; 83: 24-40
  • 10. Esposito S, Principi N, Italian Society of P, Italian Society of Pediatric I, Italian Society of Pediatric A, et al. Guidelines for the diagnosis and treatment of acute and subacute rhinosinusitis in children. J Chemother. 2008; 20(2): 147-57[DOI][PubMed]
  • 11. Kvaerner KJ, Nafstad P, Jaakkola JJ. Upper respiratory morbidity in preschool children: a cross-sectional study. Arch Otolaryngol Head Neck Surg. 2000; 126(10): 1201-6[PubMed]
  • 12. Thomas CP, Ryan M, Chapman JD, Stason WB, Tompkins CP, Suaya JA, et al. Incidence and cost of pneumonia in medicare beneficiaries. Chest. 2012; 142(4): 973-81[DOI][PubMed]
  • 13. Colice GL, Morley MA, Asche C, Birnbaum HG. Treatment costs of community-acquired pneumonia in an employed population. Chest. 2004; 125(6): 2140-5[PubMed]
  • 14. Zar HJ, Ferkol TW. The global burden of respiratory disease-impact on child health. Pediatr Pulmonol. 2014; 49(5): 430-4[DOI][PubMed]
  • 15. Khattab A, Shaheen M, Kamel T, El Faramay A, El Rahman SA, Nabil D, et al. Burden of pediatric influenza A virus infection post swine-flu H1N1 pandemic in Egypt. Asian Pac J Trop Med. 2013; 6(9): 693-8[DOI][PubMed]
  • 16. Salami A, Dellepiane M, Crippa B, Mora F, Guastini L, Jankowska B, et al. Sulphurous water inhalations in the prophylaxis of recurrent upper respiratory tract infections. Int J Pediatr Otorhinolaryngol. 2008; 72(11): 1717-22[DOI][PubMed]
  • 17. McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006; 19(3): 571-82[DOI][PubMed]
  • 18. Bosch AA, Biesbroek G, Trzcinski K, Sanders EA, Bogaert D. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog. 2013; 9(1)[DOI][PubMed]
  • 19. Keitel K, Alcoba G, Lacroix L, Manzano S, Galetto-Lacour A, Gervaix A. Observed costs and health care use of children in a prospective cohort study on community-acquired pneumonia in Geneva, Switzerland. Swiss Med Wkly. 2014; 144[DOI][PubMed]
  • 20. Santibanez P, Gooch K, Vo P, Lorimer M, Sandino Y. Acute care utilization due to hospitalizations for pediatric lower respiratory tract infections in British Columbia, Canada. BMC Health Serv Res. 2012; 12: 451[DOI][PubMed]
  • 21. Hersh AL, Jackson MA, Hicks LA, American Academy of Pediatrics Committee on Infectious D. Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics. 2013; 132(6): 1146-54[DOI][PubMed]
  • 22. Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009; 302(7): 758-66[DOI][PubMed]
  • 23. Hersh AL, Shapiro DJ, Pavia AT, Shah SS. Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics. 2011; 128(6): 1053-61[DOI][PubMed]
  • 24. Sanchez GV, Roberts RM, Albert AP, Johnson DD, Hicks LA. Effects of knowledge, attitudes, and practices of primary care providers on antibiotic selection, United States. Emerg Infect Dis. 2014; 20(12): 2041-7[DOI][PubMed]
  • 25. Cohen AL, Budnitz DS, Weidenbach KN, Jernigan DB, Schroeder TJ, Shehab N, et al. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. J Pediatr. 2008; 152(3): 416-21[DOI][PubMed]
  • 26. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010; 340[DOI][PubMed]
  • 27. Piovani D, Clavenna A, Sequi M, Cartabia M, Bortolotti A, Fortino I, et al. Reducing the costs of paediatric antibiotic prescribing in the community by implementing guideline recommendations. J Clin Pharm Ther. 2013; 38(5): 373-8[DOI][PubMed]
  • 28. Davies A. Fever in children. Nurs Stand. 2014; 29(1): 61[DOI][PubMed]
  • 29. Schaad UB, Principi N. The management of recurrent respiratory tract infections in children. Europ Infect Dis. 2012; 6(2): 111-5
  • 30. Jesenak M, Babusikova E, Ciljakova M, Banovcin P, Rennerova Z. Recurrent respiratory infections in children-definition, diagnostic approach, treatment and prevention. 2011;
  • 31. Mossad SB. Upper Respiratory Tract Infections. 2013;
  • 32. Korppi M. Recurrent respiratory infections in children: a practical approach for clinical work. Pediatr Pulmonol Suppl. 1997; 16: 144-5[PubMed]
  • 33. Schaad UB. OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. World J Pediatr. 2010; 6(1): 5-12[DOI][PubMed]
  • 34. Graham NM. The epidemiology of acute respiratory infections in children and adults: a global perspective. Epidemiol Rev. 1990; 12: 149-78[PubMed]
  • 35. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989; 160(1): 83-94[PubMed]
  • 36. Recurrent infections in children: definition and diagnostic approach. Rev Immunol Allerg Pediatr. 1988; 2: 127-34
  • 37. Wheeler JG. Evaluating the child with recurrent infections. Am Fam Physician. 1996; 54(7): 2276-82[PubMed]
  • 38. Kilic SS. Recurrent respiratory tract infection. Recent advances in pediatrics. 2004; : 1-18
  • 39. Yang KD, Hill HR. Neutrophil function disorders: Pathophysiology, prevention, and therapy. J Pediatr. 1991; 119(3): 343-54[DOI]
  • 40. Wheeler JG, Steiner D. Evaluation of humoral responsiveness in children. Pediatr Infect Dis J. 1992; 11(4): 304-10[PubMed]
  • 41. Diesner SC, Forster-Waldl E, Olivera A, Pollak A, Jensen-Jarolim E, Untersmayr E. Perspectives on immunomodulation early in life. Pediatr Allergy Immunol. 2012; 23(3): 210-23[DOI][PubMed]
  • 42. Zhang Y, Zhang Y, Gu W, He L, Sun B. Th1/Th2 cell's function in immune system. Adv Exp Med Biol. 2014; 841: 45-65[DOI][PubMed]
  • 43. Genel F, Kutukculer N. Prospective, randomized comparison of OM-85 BV and a prophylactic antibiotic in children with recurrent infections and immunoglobulin A and/or G subclass deficiency. Curr Ther Res Clin Exp. 2003; 64(8): 600-15[DOI][PubMed]
  • 44. Fete T. Respiratory problems in patients with ectodermal dysplasia syndromes. Am J Med Genet A. 2014; 164A(10): 2478-81[DOI][PubMed]
  • 45. Torres LC, Sugayama SM, Arslanian C, Sales MM, Carneiro-Sampaio M. Evaluation of the immune humoral response of Brazilian patients with Rubinstein-Taybi syndrome. Braz J Med Biol Res. 2010; 43(12): 1215-24[PubMed]
  • 46. Froom J, Culpepper L, Green LA, de Melker RA, Grob P, Heeren T, et al. A cross-national study of acute otitis media: risk factors, severity, and treatment at initial visit. Report from the International Primary Care Network (IPCN) and the Ambulatory Sentinel Practice Network (ASPN). J Am Board Fam Pract. 2001; 14(6): 406-17[PubMed]
  • 47. Kim HY, Han Y, Pyun Y, Kim J, Ahn K, Lee SI. Prolonged bedtime bottle feeding and respiratory symptoms in infants. Asia Pac Allergy. 2011; 1(1): 30-5[DOI][PubMed]
  • 48. Salah M, Abdel-Aziz M, Al-Farok A, Jebrini A. Recurrent acute otitis media in infants: analysis of risk factors. Int J Pediatr Otorhinolaryngol. 2013; 77(10): 1665-9[DOI][PubMed]
  • 49. Razi CH, Harmanci K, Abaci A, Ozdemir O, Hizli S, Renda R, et al. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J Allergy Clin Immunol. 2010; 126(4): 763-9[DOI][PubMed]
  • 50. Narinesingh SP, Whitby DJ, Davenport PJ. Moraxella catarrhalis: an unrecognized pathogen of the oral cavity? Cleft Palate Craniofac J. 2011; 48(4): 462-4[DOI][PubMed]
  • 51. Savitha MR, Nandeeshwara SB, Pradeep Kumar MJ, ul-Haque F, Raju CK. Modifiable risk factors for acute lower respiratory tract infections. Indian J Pediatr. 2007; 74(5): 477-82[PubMed]
  • 52. Musher DM. How contagious are common respiratory tract infections? N Engl J Med. 2003; 348(13): 1256-66[DOI][PubMed]
  • 53. Aymard M, Chomel JJ, Allard JP, Thouvenot D, Honegger D, Floret D, et al. Epidemiology of viral infections and evaluation of the potential benefit of OM-85 BV on the virologic status of children attending day-care centers. Respiration. 1994; 61 Suppl 1: 24-31[PubMed]
  • 54. Jara-Perez JV, Berber A. Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial. Clin Ther. 2000; 22(6): 748-59[DOI][PubMed]
  • 55. Gutierrez-Tarango MD, Berber A. Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months. Chest. 2001; 119(6): 1742-8[PubMed]
  • 56. de Martino M, Ballotti S. The child with recurrent respiratory infections: normal or not? Pediatr Allergy Immunol. 2007; 18 Suppl 18: 13-8[DOI][PubMed]
  • 57. Li Volti G, Malaponte G, Bevelacqua V, Messina A, Bianca S, Mazzarino MC, et al. Persistent high plasma levels of interleukins 18 and 4 in children with recurrent infections of the upper respiratory tract. Transplant Proc. 2003; 35(8): 2911-5[PubMed]
  • 58. Dales RE, Schweitzer I, Toogood JH, Drouin M, Yang W, Dolovich J, et al. Respiratory infections and the autumn increase in asthma morbidity. Eur Respir J. 1996; 9(1): 72-7[PubMed]
  • 59. Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008; 178(7): 667-72[DOI][PubMed]
  • 60. Koshy E, Watt H, Curcin V, Bottle A, Sharland M, Saxena S. Tonsillectomy among children with low baseline acute throat infection consultation rates in UK general practices: a cohort study. BMJ Open. 2015; 5(2)[DOI][PubMed]
  • 61. van den Aardweg MT, Boonacker CW, Rovers MM, Hoes AW, Schilder AG. Effectiveness of adenoidectomy in children with recurrent upper respiratory tract infections: open randomised controlled trial. BMJ. 2011; 343[DOI][PubMed]
  • 62. Byington CL, Barnett ED, Davies HD, Edwards KM, Jackson MA, Maldonado YA, et al. Recommendations for Prevention and Control of Influenza in Children, 2014–2015. Pediatrics. 2014; 134(5)-19
  • 63. Grohskopf LA, Olsen SJ, Sokolow LZ, Bresee JS, Cox NJ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep. 2014; 63(32): 691-7[PubMed]
  • 64. Esposito S, Marchisio P, Cavagna R, Gironi S, Bosis S, Lambertini L, et al. Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households. Vaccine. 2003; 21(23): 3162-8[PubMed]
  • 65. Patria MF, Tagliabue C, Longhi B, Esposito S. Influenza vaccination in children at high risk of respiratory disease. Ther Adv Vaccines. 2013; 1(1): 21-31[DOI][PubMed]
  • 66. Glezen WP, Gaglani MJ, Kozinetz CA, Piedra PA. Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants. J Infect Dis. 2010; 202(11): 1626-33[DOI][PubMed]
  • 67. Esposito S, Tagliabue C, Tagliaferri L, Semino M, Longo MR, Principi N. Preventing influenza in younger children. Clin Microbiol Infect. 2012; 18 Suppl 5: 42-9[DOI][PubMed]
  • 68. Esposito S, Montinaro V, Bosis S, Tagliabue C, Baggi E, Principi N. Recommendations for the use of influenza vaccine in pediatrics. Hum Vaccin Immunother. 2012; 8(1): 102-6[DOI][PubMed]
  • 69. Song A, Myojo K, Laudenslager J, Harada D, Miura T, Suzuki K, et al. Evaluation of a fully human monoclonal antibody against multiple influenza A viral strains in mice and a pandemic H1N1 strain in nonhuman primates. Antiviral Res. 2014; 111: 60-8[DOI][PubMed]
  • 70. Greenberg HB, Piedra PA. Immunization against viral respiratory disease: a review. Pediatr Infect Dis J. 2004; 23(11 Suppl)-61[PubMed]
  • 71. Bousquet J, Fiocchi A. Prevention of recurrent respiratory tract infections in children using a ribosomal immunotherapeutic agent: a clinical review. Paediatr Drugs. 2006; 8(4): 235-43[PubMed]
  • 72. Schaad UB. Prevention of paediatric respiratory tract infections: emphasis on the role of OM-85. Eur Respiratory Rev. 2005; 14(95): 74-7[DOI]
  • 73. Del-Rio-Navarro BE, Espinosa-Rosales FJ, Flenady V, Sienra-Monge JJL. Cochrane Review: Immunostimulants for preventing respiratory tract infection in children. Evid Based Child Health Cochrane Rev J. 2012; 7(2): 629-717[DOI]
  • 74. Luan H, Zhang Q, Wang L, Wang C, Zhang M, Xu X, et al. OM85-BV induced the productions of IL-1beta, IL-6, and TNF-alpha via TLR4- and TLR2-mediated ERK1/2/NF-kappaB pathway in RAW264.7 cells. J Interferon Cytokine Res. 2014; 34(7): 526-36[DOI][PubMed]
  • 75. Wybran J, Libin M, Schandene L. Activation of natural killer cells and cytokine production in man by bacterial extracts. Immunopharmacol Immunotoxicol. 1989; 11(1): 17-32[DOI][PubMed]
  • 76. Alyanakian MA, Grela F, Aumeunier A, Chiavaroli C, Gouarin C, Bardel E, et al. Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes. Diabetes. 2006; 55(1): 179-85[PubMed]
  • 77. Parola C, Salogni L, Vaira X, Scutera S, Somma P, Salvi V, et al. Selective activation of human dendritic cells by OM-85 through a NF-kB and MAPK dependent pathway. PLoS One. 2013; 8(12)[DOI][PubMed]
  • 78. Pasquali C, Salami O, Taneja M, Gollwitzer ES, Trompette A, Pattaroni C, et al. Enhanced Mucosal Antibody Production and Protection against Respiratory Infections Following an Orally Administered Bacterial Extract. Front Med (Lausanne). 2014; 1: 41[DOI][PubMed]
  • 79. Del-Rio-Navarro BE, Espinosa Rosales F, Flenady V, Sienra-Monge JJ. Immunostimulants for preventing respiratory tract infection in children. Cochrane Database Syst Rev. 2006; (4)[DOI][PubMed]
  • 80. Sopo SM, Onesimo R, Giorgio V, Fundaro C, Tabacco F, Calvani M. Efficacy of over-the-counter immunostimulants in the prevention of paediatric recurrent acute respiratory tract infections. Criticisms and pitfalls of available metanalyses. Eur Ann Allergy Clin Immunol. 2011; 43(5): 157-61[PubMed]
  • 81. Schaad UB, Mutterlein R, Goffin H, B. V-Child Study Group. . Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study. Chest. 2002; 122(6): 2042-9[PubMed]
  • 82. Maestroni GJ, Losa GA. Clinical and immunobiological effects of an orally administered bacterial extract. Int J Immunopharmacol. 1984; 6(2): 111-7[PubMed]
  • 83. Field J, Gómez-Barreto D, Del-Río-Navarro BE, Berber A. Use of OM-85 BV in primary prevention of acute respiratory tract infections in children in orphanages. Curr Ther Res. 1998; 59(6): 407-18[DOI]
  • 84. Bitar MA, Saade R. The role of OM-85 BV (Broncho-Vaxom) in preventing recurrent acute tonsillitis in children. Int J Pediatr Otorhinolaryngol. 2013; 77(5): 670-3[DOI][PubMed]
  • 85. Karaca NE, Gulez N, Aksu G, Azarsiz E, Kutukculer N. Does OM-85 BV prophylaxis trigger autoimmunity in IgA deficient children? Int Immunopharmacol. 2011; 11(11): 1747-51[DOI][PubMed]
  • 86. Esposito S, Marchisio P, Prada E, Daleno C, Porretti L, Carsetti R, et al. Impact of a mixed bacterial lysate (OM-85 BV) on the immunogenicity, safety and tolerability of inactivated influenza vaccine in children with recurrent respiratory tract infection. Vaccine. 2014; 32(22): 2546-52[DOI][PubMed]
  • 87. Zaniolo O, Pradelli L, Eandi M. Effectiveness of the prevention of upper respiratory tract infections by a bacterial extract non-specific immunostimulant (OM-85). Treat Programs. 2013; 6(3): 169-84
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments